Skip to main content
. 2015 Mar 5;8:131–138. doi: 10.2147/JPR.S74900

Table 4.

Charlson comorbidity prevalence of the evaluated cohorts during 2011 and univariate odds ratios (ORs) for a fibromyalgia (FM) diagnosis

Comorbid condition Patients, n (%)
OR (95% CI) P
FM (n=4,296) No-FM (n=583,665)
Any Charlson comorbidity 1,758 (40.9) 158,850 (27.2) 1.9 (1.7, 2.0) <0.0001
 Myocardial infarction 103 (2.4) 11,936 (2.0) 1.2 (1.0, 1.4) 0.1133
 Congestive heart failure 169 (3.9) 17,804 (3.1) 1.3 (1.1, 1.5) 0.0013
 Peripheral vascular disease 141 (3.3) 12,922 (2.2) 1.5 (1.3, 1.8) <0.0001
 Cerebrovascular disease 244 (5.7) 21,416 (3.7) 1.6 (1.4, 1.8) <0.0001
 Dementia 10 (0.2) 2,191 (0.4) 0.6 (0.3, 1.2) 0.1012
 Chronic obstructive pulmonary disease 816 (19.0) 52,515 (9.0) 2.4 (2.2, 2.6) <0.0001
 Rheumatologic disease 207 (4.8) 8,326 (1.4) 3.5 (3.0, 4.0) <0.0001
 Peptic ulcer disease 80 (1.9) 3,195 (0.5) 3.4 (2.8, 4.3) <0.0001
 Mild liver disease 28 (0.7) 2,849 (0.5) 1.3 (0.9, 1.9) 0.1449
 Diabetes 699 (16.3) 73,420 (12.6) 1.4 (1.2, 1.5) <0.0001
 Diabetes with chronic complications 181 (4.2) 13,559 (2.3) 1.8 (1.6, 2.1) <0.0001
 Hemiplegia or paraplegia 19 (0.4) 1,622 (0.3) 1.6 (1.0, 2.5) 0.0608
 Renal disease 204 (4.7) 21,305 (3.7) 1.3 (1.1, 1.5) 0.0003
 Malignancy 0 (0.0) 0 (0.0)
 Moderate or severe liver disease 11 (0.3) 1,232 (0.2) 1.2 (0.7, 2.2) 0.5360
 Metastatic solid tumor 0 (0.0) 0 (0.0)
 AIDS Not reported Not reported

Abbreviation: CI, confidence interval.